These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 4843162)

  • 1. Relative toxicity of methotrexate in several tissues of mice bearing Lewis lung carcinoma.
    Zaharko DS; Dedrick RL; Peale AL; Drake JC; Lutz RJ
    J Pharmacol Exp Ther; 1974 Jun; 189(3):585-92. PubMed ID: 4843162
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential cell permeability and the basis for selective activity of methotrexate during therapy of the L1210 leukemia.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1973 Jun; 33(6):1290-4. PubMed ID: 4718678
    [No Abstract]   [Full Text] [Related]  

  • 3. Relative biochemical aspects of low and high doses of methotrexate in mice.
    Zaharko DS; Fung WP; Yang KH
    Cancer Res; 1977 Jun; 37(6):1602-7. PubMed ID: 870175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of chemotherapeutic agents on the incorporation of DNA precursors by experimental brain tumors.
    Shapiro WR
    Cancer Res; 1972 Oct; 32(10):2178-85. PubMed ID: 5080762
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of DNA synthesis in short-term cultures of mammalian cells in the evaluation of the reaction of tumor and normal tissues to irradiation and hyperthermia].
    Synzynys BI; Kolesnikova AI; Konopliannikova AG
    Radiobiologiia; 1985; 25(2):179-84. PubMed ID: 4001315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of inhibition of synthesis of DNA in tumors and host tissues after single doses of nitrosoureas.
    Wheeler GP; Alexander JA
    Cancer Res; 1974 Aug; 34(8):1957-64. PubMed ID: 4842249
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose methotrexate therapy with citrovorum factor: a pharmacologic perspective in murine tumor models.
    Sirotnak FM; Donsbach RC; Dorick DM; Moccio DM
    Cancer Treat Rep; 1977 Jul; 61(4):565-74. PubMed ID: 301778
    [No Abstract]   [Full Text] [Related]  

  • 8. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues.
    Chabner BA; Young RC
    J Clin Invest; 1973 Aug; 52(8):1804-11. PubMed ID: 4719662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of inhibition of cytidine deaminase by tetrahydrouridine on the utilization of deoxycytidine and 5-bromodeoxycytidine for deoxyribonucleic acid synthesis.
    Cooper GM; Greer S
    Mol Pharmacol; 1973 Nov; 9(6):698-703. PubMed ID: 4762631
    [No Abstract]   [Full Text] [Related]  

  • 10. The mechanism of action of methotrexate. II. Augmentation by vincristine of inhibition of deoxyribonucleic aic synthesis by methotrexate in Ehrlich ascites tumor cells.
    Goldman ID; Fyfe MJ
    Mol Pharmacol; 1974 Mar; 10(2):275-82. PubMed ID: 4859543
    [No Abstract]   [Full Text] [Related]  

  • 11. Biologic characterization of the subcutaneously implanted Lewis lung tumor.
    Mayo JG
    Cancer Chemother Rep 2; 1972 Nov; 3(1):325-30. PubMed ID: 4660735
    [No Abstract]   [Full Text] [Related]  

  • 12. L-asparaginase induced alteration of amethopterin (methotrexate) activity in mouse leukemia L5178Y.
    Capizzi RL; Summers WP; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():302-11. PubMed ID: 5289422
    [No Abstract]   [Full Text] [Related]  

  • 13. Preferential inhibition of DNA synthesis in mouse hemopoietic cells by halothane.
    Evenwel RF; Keizer HJ; van Putten LM
    Cancer Res; 1976 Sep; 36(9 pt.1):3156-9. PubMed ID: 975081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 5-fluorouracil on 5-fluorodeoxyuridine 5'-monophosphate and 2-deoxyuridine 5'-monophosphate pools, and DNA synthesis in solid mouse L1210 and rat Walker 256 tumors.
    Klubes P; Connelly K; Cerna I; Mandel HG
    Cancer Res; 1978 Aug; 38(8):2325-31. PubMed ID: 667828
    [No Abstract]   [Full Text] [Related]  

  • 15. Growth rate and cell kill.
    Hryniuk WM; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():330-42. PubMed ID: 5289425
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitumor activity of a folate-cleaving enzyme, carboxypeptidase G 1 .
    Chabner BA; Chello PL; Bertino JR
    Cancer Res; 1972 Oct; 32(10):2114-9. PubMed ID: 5080761
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of thymidylate synthetase and dihydrofolate reductase enzymes in vitro and in vivo.
    Kawai M; Hillcoat BL
    Cancer Res; 1974 Jul; 34(7):1619-26. PubMed ID: 4833915
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic basis for differences in methotrexate sensitivity of normal proliferative tissues in the mouse.
    Sirotnak FM; Moccio DM
    Cancer Res; 1980 Apr; 40(4):1230-4. PubMed ID: 7357552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of solid tumor metastases with a high-molecular-weight derivative of methotrexate.
    Chu BC; Whiteley JM
    J Natl Cancer Inst; 1979 Jan; 62(1):79-82. PubMed ID: 281578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake and distribution of 3 H-methotrexate by the murine ependymoblastoma.
    Levin VA; Clancy TP; Ausman JI; Rall DP
    J Natl Cancer Inst; 1972 Apr; 48(4):875-83. PubMed ID: 4537157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.